- Home
- WES vs ASND Comparison
WES vs ASND Comparison
Compare WES & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WES | ASND |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 17.7B |
| IPO Year | 2012 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WES | ASND |
|---|---|---|
| Price | $45.46 | $225.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 16 |
| Target Price | $41.71 | ★ $281.50 |
| AVG Volume (30 Days) | 739.5K | ★ 742.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 8.81% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $3,843,403,000.00 | N/A |
| Revenue This Year | $6.42 | $96.35 |
| Revenue Next Year | $6.99 | $44.91 |
| P/E Ratio | $14.73 | ★ N/A |
| Revenue Growth | ★ 6.61 | N/A |
| 52 Week Low | $36.90 | $186.05 |
| 52 Week High | $50.07 | $282.15 |
Technical Indicators
Market Signals| Indicator | WES | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 33.99 | 34.87 |
| Support Level | $45.42 | $213.28 |
| Resistance Level | $48.32 | $246.56 |
| Average True Range (ATR) | 1.01 | 10.27 |
| MACD | -0.38 | -3.54 |
| Stochastic Oscillator | 9.00 | 10.28 |
Price Performance
Historical ComparisonAbout WES Western Midstream Partners LP
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma) and Texas.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.